OWENS & MINOR, INC. NYSE-OMI RECENT PIE Trailing: 15.2 RELATIVE DIVD PRICE RATIO Median: 17.0 / PE RATIO YLD 2171 anal 970 20 21 22 2R 44 51 50 4 R VALUE LINE IIICAR 2. Hinh 10 o 170 1R41 Tarant Drina Danas TIMELINESS 2 Lowered 2/2006 SAFETY 3 New 12790 TECHNICAL 3 Raised 9/2008 BETA 70 (1.00 - Market) 2012-14 PROJECTIONS Ann'l Total Price Gain Return High 70 (+90%) 19% Low 8% Insider Decisions AM J J A S O N D to Buy o o o o o o o o Options 541iiii2 4 4 1 1 1 1 1 1 0 Institutional Decisions 102008 202008 302003 to Bu 114 139 113 CAPITAL STRUCTURE as of 12/31/08 Total Debt $359.2 mill. Due in 5 Yrs Nil LT Debt $359.2 mil. LT Interest S25.0 mill. (LT int. earned: 9.1x) (35% of Capi) Leases, Uncapitalized Annual rentals $51.7 mill. Pension Assets $29.2 mill. Oblig. $30.6 mil Pfd Stock None .70 2008 2009 2010 VALUE LINE PUB., INCL 12-14 176.66 192.77 202.40 Sales per sh 220.00 3.00 3.25 3.70 "Cash Flow" per sh 4.65 243 2.65 2.90 Earnings per sh 3.75 .80 .92 1.00 Div'ds Decl'd per sh B 1.20 .65 .75 Cap Spending persh 1.00 16.80 19.75 23.10 Book Value per sh 35.00 41.00 41.50 42.00 Common Shs Outsig 45.00 17.9 Bold figures are Avg Ann'I PE Ratio 15.0 1.10 Value Line Relative P/E Ratio 1.00 1.8% estimates Avg Ann'l Div'd Yield 2.9% 7243.2 8000 8500 Sales (Smill) 9900 2.9% 3.0% 3.1% Operating Margin 3.5% 22.0 25.0 30.0 Depreciation (Smill) 40.0 101.3 110 125 Net Profit (Smill) 170 38.5% 39.0% 40.0% Income Tax Rate 40.0% 1.3% 1.4% 1.5% Net Profit Margin 1.7% 5. 2.1 Common Stock 41,376,591 shs. as of 10/31/08 MARKET CAP: $1.5 billion (Mid Cap) CURRENT POSITION 2006 2007 12/31/08 SMILL) Cash Assets 14.0 Receivables 539.2 462.4 5213 Inventory (LIFO) 666.5 581.6 679.0 Other 56.0 43.7 103.5 Current Assets 1266.8 1069.8 1317.8 Accts Payable 542.6 469.1 517.9 Debt Due Other 127.9 99.3 155.6 Current Liab. 670.5568.4 673.5 ANNUAL RATES Past Past Est'd '05-'07 of change per sh) 10 Yrs. 5 Yrs. to 12-14 Sales 4.0% 5.0% 6.5% "Cash Flow" 12.0% 5.0% 10.5% Earnings 22.0% 8.0% 13.0% Dividends 13.0% 17.0% 10.5% Book Value 13.0% 14.5% 14.0% WEST PHARM. NYSE-WST Trailing: 14.6 RELATIVE PRICE 33.96 RTO 15.40 (.1.32 1.8% YAKE Median: 18.0 / PE RATIO LINE TIMELINESS 3 Lowered 227/09 SAFETY 3 Lowered 12304 TECHNICAL 3 Lowered 12/1900 BETA 80 (1.00 - Market) 2012-14 PROJECTIONS Ann'l Total Price Gain Return High 70 (+105%) 21% LOW 45 (+35%) Insider Decisions AMJ JASON D to Buy Opions 1 10 05 10 10 19 Sel 0 50090000 2008 2009 2010 VALUE LINE PUB., NC 12-14 31.40 30.30 31.95 Sales per sh 41.55 4.45 4.15 4.50 "Cash Flow" per sh 6.15 2.38 2.15 2.40 Earnings per sh 3.45 57 .60 .60 Div'ds Decl'd per shu .64 3.80 3.80 3.80 Cap'l Spending per sh 3.80 15.50 17.30 19.30 Book Value per shC 27.20 38.50 33.50 33.50 Common Shs Outstg 34.00 180 Bold figures are Avg Ann'I PE Ratio 17.0 1.07 Value Line Relative P/E Ratio 1.15 1.3% estinates Avg Ann'l Div'd Yield 1.7% CAPITAL STRUCTURE as of 9/30/08 Total Debt $382.5 mill. Due in 5 yrs $88.1 mill. LT Debt $382.0 mill LT Interest $20.0 mill. Inc. $162 mill 4.0% sub notes (47) cv. into 17.83 shs. at $56.07. (LT interest eamed: 10.8x; total interest coverage: 8.2x) (33% of Cap) Leases, Uncapitalized Annual rentals $12.0 mill. Pension Assets-12/07 $216.9 mill. Oblig. $231.7 mill. Pfd Stock None Common Stock 32,715,965 shares as of 10/31/08 MARKET CAP: $1.1 billion (Mid Cap) CURRENT POSITION 2006 2007 9/30/08 9%
